Literature DB >> 16499284

Potential applications of siRNA in hepatitis C virus therapy.

Robert Smolic1, Martina Volarevic, Catherine H Wu, George Y Wu.   

Abstract

Small interfering RNAs (siRNAs) are short RNA duplexes approximately 21 nucleotides long. When introduced into mammalian cells, siRNA can silence specific gene expression. Hepatitis C virus (HCV) replicates in the cytoplasm of liver cells without integration into the host genome. Because the HCV genome is a single-stranded RNA that functions both as a messenger RNA and as a viral replication template, destruction of HCV RNA could eliminate not only virally directed protein synthesis, but also viral replication. It has been demonstrated that siRNAs interfere with HCV gene expression and replication, and this review will describe the use of RNAi as a tool to inhibit HCV gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16499284

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  2 in total

1.  Supportive Oligonucleotide Therapy (SOT) as an Alternative Treatment Option in Cancer: A Preliminary Study.

Authors:  Ioannis Papasotiriou; Georgios Beis; Aggelos C Iliopoulos; Panagiotis Apostolou
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

2.  Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene.

Authors:  Xiaoyuan Kong; Weidong Zhang; Richard F Lockey; Alexander Auais; Giovanni Piedimonte; Shyam S Mohapatra
Journal:  Genet Vaccines Ther       Date:  2007-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.